Sarah K. Lyons
YOU?
Author Swipe
View article: Transitioning adolescents with rare forms of diabetes to adult care: challenges and perspectives
Transitioning adolescents with rare forms of diabetes to adult care: challenges and perspectives Open
Background Adolescents and young adults (AYA) with rare forms of diabetes – including Wolfram syndrome (WS), Alström syndrome (AS), Bardet-Biedl syndrome (BBS), and maturity-onset diabetes of the young (MODY) – face unique challenges durin…
A Systematic Review of Factors Associated With Transition Readiness and the Transfer to Adult Health Care for Young People With Diabetes Open
This systematic review describes factors associated with transition readiness and the transfer of care from pediatric to adult health care services among adolescents and young adults with diabetes. Overall, thirty-three international nonin…
<b>A Systematic Review of Factors Associated With Transition Readiness and the Transfer to Adult Health Care for Young People With Diabetes</b> Open
This systematic review describes factors associated with transition readiness and the transfer of care from pediatric to adult health care services among adolescents and young adults with diabetes. Overall, thirty-three international nonin…
<b>A Systematic Review of Factors Associated With Transition Readiness and the Transfer to Adult Health Care for Young People With Diabetes</b> Open
This systematic review describes factors associated with transition readiness and the transfer of care from pediatric to adult health care services among adolescents and young adults with diabetes. Overall, thirty-three international nonin…
View article: The first live term birth following uterus transplantation in Australia
The first live term birth following uterus transplantation in Australia Open
Objective To report the first live birth following uterus transplantation in Australia. Study design Case report. Setting, participant The first participant in the uterus transplantation research study program at the Royal Hospital for Wom…
Transition between pediatric and adult diabetes healthcare services: an online global survey of experiences and perceptions of young people with diabetes and their carers Open
Introduction Young adults with diabetes face many challenges during emerging adulthood. Our study aimed to identify the experiences and perceptions of people with diabetes (PwD) (aged 14-25 years) and their carers around transition plannin…
View article: Intravenous lipid-siRNA conjugate mediates gene silencing at the blood-brain barrier and blood-CSF barrier
Intravenous lipid-siRNA conjugate mediates gene silencing at the blood-brain barrier and blood-CSF barrier Open
Barriers of the central nervous system (CNS), such as the blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier (BCSFB), regulate the two-way exchange of material between the blood and CNS. These barriers pose a considerable chal…
Initiating Insulin Pumps in Youth with New-onset Type 1 Diabetes: A Quality Improvement Initiative Open
Introduction: Insulin pump therapy is recommended for youth with type 1 diabetes (T1D) as it enhances quality of life and improves glycemic management. We led a quality improvement initiative to increase insulin pump use in youth younger t…
Hypertriglyceridemia in New‐Onset Type 1 Pediatric Diabetes Open
Hypertriglyceridemia (HTG) in the setting of newly diagnosed diabetes is common in both adult and pediatric populations, as insulin deficiency promotes lipolysis and impairs triglyceride (TG) clearance. Severe HTG (defined as TG levels abo…
The Design of the Electronic Health Record in Type 1 Diabetes Centers: Implications for Metrics and Data Availability for a Quality Collaborative Open
Background: Systematic and comprehensive data acquisition from the electronic health record (EHR) is critical to the quality of data used to improve patient care. We described EHR tools, workflows, and data elements that contribute to core…
Benchmarking Diabetes Technology Use Among 21 U.S. Pediatric Diabetes Centers Open
The American Diabetes Association’s Standards of Care in Diabetes recommends the use of diabetes technology such as continuous glucose monitoring systems and insulin pumps for people living with type 1 diabetes. Unfortunately, there are mu…
<b>Benchmarking Diabetes Technology Use Among 21 U.S. Pediatric Diabetes Centers</b> Open
The American Diabetes Association’s Standards of Care in Diabetes recommends the use of diabetes technology such as continuous glucose monitoring systems and insulin pumps for people living with type 1 diabetes. Unfortunately, there are mu…
<b>Benchmarking Diabetes Technology Use Among 21 U.S. Pediatric Diabetes Centers</b> Open
The American Diabetes Association’s Standards of Care in Diabetes recommends the use of diabetes technology such as continuous glucose monitoring systems and insulin pumps for people living with type 1 diabetes. Unfortunately, there are mu…
Continuous Glucose Monitoring Provides Durable Glycemic Benefit in Adolescents and Young Adults with Type 1 Diabetes: 12-Month Follow-Up Results Open
Objective. To further evaluate glycemic outcomes during the observational extension phase of the Continuous Glucose Monitoring (CGM) Intervention for Teens and Young Adults randomized clinical trial (RCT). Subjects and Methods. Following a…
View article: Addendum. 2. Classification and Diagnosis of Diabetes: <i>Standards of Care in Diabetes—2023</i> . Diabetes Care 2023;46(Suppl. 1):S19–S40
Addendum. 2. Classification and Diagnosis of Diabetes: <i>Standards of Care in Diabetes—2023</i> . Diabetes Care 2023;46(Suppl. 1):S19–S40 Open
Section 2, “Classification and Diagnosis of Diabetes,” of the Standards of Care in Diabetes—2023 has been updated to refine the diagnostic criteria for type 1 diabetes based on recent U.S. Food and Drug Administration approval of a new dru…
View article: Addendum. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: <i>Standards of Care in Diabetes—2023</i>. Diabetes Care 2023;46(Suppl. 1):S49–S67
Addendum. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: <i>Standards of Care in Diabetes—2023</i>. Diabetes Care 2023;46(Suppl. 1):S49–S67 Open
Section 4, “Comprehensive Medical Evaluation and Assessment of Comorbidities,” of the Standards of Care in Diabetes—2023 has been updated to reflect the current clinical knowledge and evidence in nonalcoholic fatty liver disease (NAFLD).
View article: Addendum. 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: <i>Standards of Care in Diabetes—2023</i>. Diabetes Care 2023;46(Suppl. 1):S41–S48
Addendum. 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: <i>Standards of Care in Diabetes—2023</i>. Diabetes Care 2023;46(Suppl. 1):S41–S48 Open
Section 3, "Prevention or Delay of Type 2 Diabetes and Associated Comorbidities," of the Standards of Care in Diabetes—2023 has been updated based on recent U.S. Food and Drug Administration approval of a new drug to delay the incidence of…
View article: Erratum. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: <i>Standards of Care in Diabetes—2023</i>. Diabetes Care 2023;46(Suppl. 1):S49–S67
Erratum. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: <i>Standards of Care in Diabetes—2023</i>. Diabetes Care 2023;46(Suppl. 1):S49–S67 Open
In the section “Assessment of Comorbidities” of the article cited above, the subsections “Hepatitis C Infection,” “Pancreatitis,” “Fractures,” “Sensory Impairment,” and “Low Testosterone in Men,” present in the 2022 guidelines, were inadve…
View article: Erratum. 2. Classification and diagnosis of diabetes: <i>Standards of Care in Diabetes—2023</i>. Diabetes Care 2023;46(Suppl. 1):S19–S40
Erratum. 2. Classification and diagnosis of diabetes: <i>Standards of Care in Diabetes—2023</i>. Diabetes Care 2023;46(Suppl. 1):S19–S40 Open
In Table 2.3 of the article cited above, the hypertension risk factor was incorrectly defined as “≥140/90 mmHg or on therapy for hypertension”; this has been corrected to “≥130/80 or on therapy for hypertension.” More information on update…
View article: Erratum. 10. Cardiovascular disease and risk management: <i>Standards of Care in Diabetes—2023</i>. Diabetes Care 2023;46(Suppl. 1):S158–S190
Erratum. 10. Cardiovascular disease and risk management: <i>Standards of Care in Diabetes—2023</i>. Diabetes Care 2023;46(Suppl. 1):S158–S190 Open
Fig. 10.2 of the article cited above provides recommendations for the treatment of confirmed hypertension in people with diabetes. Due to a composition error, the initial blood pressure range for the left side of the algorithm was given as…
View article: 12. Retinopathy, Neuropathy, and Foot Care:<i>Standards of Care in Diabetes—2023</i>
12. Retinopathy, Neuropathy, and Foot Care:<i>Standards of Care in Diabetes—2023</i> Open
The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and to…
View article: 9. Pharmacologic Approaches to Glycemic Treatment: <i>Standards of Care in Diabetes—2023</i>
9. Pharmacologic Approaches to Glycemic Treatment: <i>Standards of Care in Diabetes—2023</i> Open
The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and to…
View article: 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: <i>Standards of Care in Diabetes—2023</i>
8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: <i>Standards of Care in Diabetes—2023</i> Open
The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and to…
View article: 11. Chronic Kidney Disease and Risk Management: <i>Standards of Care in Diabetes—2023</i>
11. Chronic Kidney Disease and Risk Management: <i>Standards of Care in Diabetes—2023</i> Open
The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and to…
View article: 1. Improving Care and Promoting Health in Populations: <i>Standards of Care in Diabetes—2023</i>
1. Improving Care and Promoting Health in Populations: <i>Standards of Care in Diabetes—2023</i> Open
The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and to…
View article: 15. Management of Diabetes in Pregnancy:<i>Standards of Care in Diabetes—2023</i>
15. Management of Diabetes in Pregnancy:<i>Standards of Care in Diabetes—2023</i> Open
The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and to…